Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Olympia WA, Seattle WA, Vancouver WA, Portland OR,
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07085767
Phase 3, Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Olympia WA, Seattle WA, Edmonds WA, Everett WA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Olympia WA, Portland OR, Gresham OR, Beaverton OR,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Olympia WA, Portland OR, Spokane WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Olympia WA, Portland OR, Eugene OR, Reno NV, Edmonton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Olympia WA, Santa Barbara CA, Albuquerque NM,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT05920356
Phase 3, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Location: Olympia WA, Abbotsford British Columbia, Billings MT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06758401
Phase 3, Recruiting
AIMS Cancer Outcomes Study
for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute
Sex: All
Age: 0+
Code: NCT04495790
Recruiting
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Bremerton WA, Meridian ID, Visalia CA, Arcadia CA,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
for
Head and Neck Squamous Cell Carcinoma,
Location: Bremerton WA, Weston WI
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT02734537
Phase 2, Recruiting
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
for
Influenza, Human+COVID-19
Location: Seattle WA, Fair Oaks CA, San Diego CA, Austin TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65 - 70+
Code: NCT07464314
Phase 1, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Seattle WA, Olympia WA, San Francisco CA,